The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
The Genetic Landscape and Epidemiology of Phenylketonuria
Open accessAbstract
Phenylketonuria (PKU), caused by variants in the phenylalanine hydroxylase (PAH) gene, is the most common autosomal-recessive Mendelian phenotype of amino acid metabolism. We estimated that globally 0.45 million individuals have PKU, with global prevalence 1:23,930 live births (range 1:4,500 [Italy]-1:125,000 [Japan]). Comparing genotypes and metabolic phenotypes from 16,092 affected subjects revealed differences in disease severity in 51 countries from 17 world regions, with the global phenotype distribution of 62% classic PKU, 22% mild PKU, and 16% mild hyperphenylalaninemia. A gradient in genotype and phenotype distribution exists across Europe, from classic PKU in the east to mild PKU in the southwest and mild hyperphenylalaninemia in the south. The c.1241A>G (p.Tyr414Cys)-associated genotype can be traced from Northern to Western Europe, from Sweden via Norway, to Denmark, to the Netherlands. The frequency of classic PKU increases from Europe (56%) via Middle East (71%) to Australia (80%). Of 758 PAH variants, c.1222C>T (p.Arg408Trp) (22.2%), c.1066-11G>A (IVS10-11G>A) (6.4%), and c.782G>A (p.Arg261Gln) (5.5%) were most common and responsible for two prevalent genotypes: p.[Arg408Trp];[Arg408Trp] (11.4%) and c.[1066-11G>A];[1066-11G>A] (2.6%). Most genotypes (73%) were compound heterozygous, 27% were homozygous, and 55% of 3,659 different genotypes occurred in only a single individual. PAH variants were scored using an allelic phenotype value and correlated with pre-treatment blood phenylalanine concentrations (n = 6,115) and tetrahydrobiopterin loading test results (n = 4,381), enabling prediction of both a genotype-based phenotype (88%) and tetrahydrobiopterin responsiveness (83%). This study shows that large genotype databases enable accurate phenotype prediction, allowing appropriate targeting of therapies to optimize clinical outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blau, N., van Spronsen, F. J., & Levy, H. L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60961-0 · Cited by 1,086
Self-citationPhenylalanine hydroxylase deficiency: diagnosis and management guideline
Vockley, J., Andersson, H. C., Antshel, K. M., Braverman, N. E., Burton, B. K., Frazier, D. M., Mitchell, J., Smith, W. E., Thompson, B. H., & Berry, S. A. (2014) · Genetics in Medicine · doi:10.1038/gim.2013.157 · Cited by 731
Self-citationKey European guidelines for the diagnosis and management of patients with phenylketonuria
van Spronsen, F. J., van Wegberg, A. M., Ahring, K., Bélanger-Quintana, A., Blau, N., Bosch, A. M., Burlina, A., Campistol, J., Feillet, F., Giżewska, M., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30320-5 · Cited by 425
Self-citationMonogenic traits are not simple: lessons from phenylketonuria
Scriver, C. R., & Waters, P. J. (1999) · Trends in Genetics · doi:10.1016/s0168-9525(99)01761-8 · Cited by 420
ThePAH gene, phenylketonuria, and a paradigm shift
Scriver, C. R. (2007) · Human Mutation · doi:10.1002/humu.20526 · Cited by 336
Phenylketonuria Scientific Review Conference: State of the science and future research needs
Camp, K. M., Parisi, M. A., Acosta, P. B., Berry, G. T., Bilder, D. A., Blau, N., Bodamer, O. A., Brosco, J. P., Brown, C. S., Burlina, A. B., et al. (2014) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2014.02.013 · Cited by 261
Self-citationPhenylalanine hydroxylase: Function, structure, and regulation
Flydal, M. I., & Martinez, A. (2013) · IUBMB Life · doi:10.1002/iub.1150 · Cited by 232
Güttler, F. (1980) · PubMed · Cited by 198
Phenylketonuria mutations in Europe
Zschocke, J. (2003) · Human Mutation · doi:10.1002/humu.10192 · Cited by 160
Self-citationMolecular genetics and diagnosis of phenylketonuria: state of the art
Blau, N., Shen, N., & Carducci, C. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.923760 · Cited by 128
Self-citationNewborn screening: Experiences in the Middle East and North Africa
Saadallah, A. A. A., & Rashed, M. S. (2007) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-007-0660-5 · Cited by 104
Allelic phenotype values: a model for genotype-based phenotype prediction in phenylketonuria
Garbade, S. F., Shen, N., Himmelreich, N., Haas, D., Trefz, F. K., Hoffmann, G. F., Burgard, P., & Blau, N. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0081-x · Cited by 95
Self-citationMultiple origins for phenylketonuria in Europe.
Eisensmith, R. C., Okano, Y., Dasovich, M., Wang, T., Güttler, F., Lou, H. C., Guldberg, P., Lichter‐Konecki, U., Konecki, D. S., & Svensson, E. (1992) · PubMed · Cited by 86
Self-citationMuntau, A. C., Adams, D. J., Bélanger-Quintana, A., Bushueva, T. V., Cerone, R., Chien, Y., Chiesa, A. E., Coşkun, T., Heras, J. D. L., Feillet, F., et al. (2019) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2019.04.004 · Cited by 85
Self-citationPhenylketonuria in a low incidence population: molecular characterisation of mutations in Finland.
Guldberg, P., Henriksen, K. F., Sipilä, I., Güttler, F., & de la Chapelle, A. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.12.976 · Cited by 62
Phenylketonuria missense mutations in the Mediterranean
Okano, Y., Wang, T., Eisensmith, R. C., Longhi, R. C., Riva, E., Giovannini, M., Cerone, R., Romano, C., & Woo, S. L. C. (1991) · Genomics · doi:10.1016/0888-7543(91)90225-4 · Cited by 58
Alternative therapies to address the unmet medical needs of patients with phenylketonuria
Blau, N., & Longo, N. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1013030 · Cited by 55
Self-citationOkano, Y., Kudo, S., Nishi, Y., et al. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2011.10 · Cited by 54
Danecka, M. K., Woidy, M., Zschocke, J., Feillet, F., Muntau, A. C., & Gersting, S. W. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102621 · Cited by 48
Self-citationShen, N., Heintz, C., Thiel, C., Okun, J. G., Hoffmann, G. F., & Blau, N. (2016) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.01.004 · Cited by 45
Self-citationDominant versus recessive: Molecular mechanisms in metabolic disease
Zschocke, J. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-1016-5 · Cited by 33 · cited 1×
“This calculation was based on the fact that the milder variant (with a higher APV) is always dominant over the severe one.(15,16)”
Self-citationA role for overdominant selection in phenylketonuria? Evidence from molecular data
Krawczak, M., & Zschocke, J. (2003) · Human Mutation · doi:10.1002/humu.10205 · Cited by 33
Self-citationPhenylketonuria splice mutation (EXON6nt-96Ag) masquerading as missense mutation (Y204C)
Ellingsen, S., Knappskog, P. M., & Eiken, H. G. (1997) · Human Mutation · Cited by 28
Réblová, K., Hrubá, Z., Procházková, D., Pazdírková, R., Pouchlá, S., & Fajkusová, L. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.01.006 · Cited by 23
Konecki, D. S., Schlotter, M., Trefz, F. K., & Lichter‐Konecki, U. (1991) · Human Genetics · doi:10.1007/bf00197153 · Cited by 18
Self-citationLilleväli, H., Reinson, K., Muru, K., Simenson, K., Murumets, Ü., Möls, T., & Õunap, K. (2017) · JIMD Reports · doi:10.1007/8904_2017_61 · Cited by 5
Cited by
van Spronsen, F. J., Blau, N., Harding, C., Burlina, A., Longo, N., & Bosch, A. M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00267-0 · Cited by 497
Self-citationKrämer, J., Kang, R., Grimm, L. M., De Cola, L., Picchetti, P., & Biedermann, F. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00746 · Cited by 449
Genetically Engineered Microorganisms and Their Impact on Human Health
Mahdizade Ari, M., Dadgar, L., Elahi, Z., Ghanavati, R., & Taheri, B. (2024) · International Journal of Clinical Practice · doi:10.1155/2024/6638269 · Cited by 67
Metadata
- Authors
- Hillert, A., Anikster, Y., Belanger-Quintana, A., Burlina, A., Burton, B. K., Carducci, C., Chiesa, A. E., Christodoulou, J., Đorđević, M., Desviat, L. R., Eliyahu, A., Evers, R. A. F., Fajkusova, L., Feillet, F., Bonfim-Freitas, P. E., Giżewska, M., Gundorova, P., Karall, D., Kneller, K., Kutsev, S. I., Leuzzi, V., Levy, H. L., Lichter-Konecki, U., Muntau, A. C., Namour, F., Oltarzewski, M., Paras, A., Perez, B., Polak, E., Polyakov, A. V., Porta, F., Rohrbach, M., Scholl-Bürgi, S., Spécola, N., Stojiljković, M., Shen, N., Santana-da Silva, L. C., Skouma, A., van Spronsen, F., Stoppioni, V., Thöny, B., Trefz, F. K., Vockley, J., Yu, Y., Zschocke, J., Hoffmann, G. F., Garbade, S. F., & Blau, N.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2020-08
- Volume
- 107
- Issue
- 2
- Pages
- 234-250
- ISSN
- 0002-9297 (ISSN-L)
- OpenAlex
- W3042266870
- Cited by
- 386
- References
- 26
- FWCI
- 20.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.